Navigation Links
Protect patients from exploitation by alternative medicines industry

It is time to protect patients from “vile and cynical exploitation?by the alternative medicines industry, argues a cancer expert in this week’s BMJ.

It is estimated that up to 80% of all patients with cancer take a complementary treatment or follow a dietary programme to help treat their cancer, writes Jonathan Waxman, Professor of Oncology at Imperial College London.

Yet the rationale for the use of many of these approaches is obtuse ?one might even be tempted to write misleading, he says.

Indeed the claims made by companies to support the sales of such products may be overtly and malignly incorrect and, in many cases, the products may be doctored by chemicals borrowed from the conventional pharmaceutical industry. The reason that these products are accessible to patients is that they are not subject to the testing of pharmaceuticals because they are classified as food supplements.

So why do patients take alternative medicines" Why is science disregarded" How can it be that treatments that don’t work are regarded as life saving"

Waxman believes that it is because the complementary therapists offer something that doctors cannot offer ?hope. If you eat this, take that, avoid this, and really believe this then we can promise you sincerely that you will be cured.

And if the patient is not cured, it is the patient who has failed, not the alternative therapy. The patient has let down the alternative practitioner and disappointed his family who have encouraged his “treatment.?

As well as the complementary medicines they take, many patients will have changed their diets in order to cure their cancers, says the author. But although there is a strong dietary basis to the development of cancer, once cancer has been diagnosed no change in diet will lead to any improvement in cancer outcomes, he writes.

Why do patients change their diet" For some it is a way of taking back some control of a situation t hat is entirely out of their control, says Waxman. For others it is because of the pressure put on them by families, friends or vested interest groups to “go organic.?

“It’s time for legislation to focus on a particularly vulnerable section of our society and do something to limit the exploitation of our patients,?he says. Why not subject the alternative medicines industry to the level of scrutiny that defines pharmaceuticals"

“Reclassify these agents as drugs - for this is after all how they are marketed - and protect our patients from vile and cynical exploitation whose intellectual basis, at best, might be viewed as delusional. The current EU initiative to bring forward legislation on this matter is welcomed.?
'"/>

Source:BMJ-British Medical Journal


Related biology news :

1. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
2. Researchers Find Drug May Give Some Cardiac Protection 24 Hours After Heart Attack
3. Protecting endangered species helps reduce poverty
4. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. Potential Cure for Lymphoma in HIV patients
7. Ophthalmologists implant five patients with artificial silicon retina microchip
8. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
9. Measuring hormone cuts antibiotic use in half in pneumonia patients
10. Doctors closer to using gene analysis to help trauma patients
11. Research shows smoking adds a decade to reproductive age of IVF patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... of multiple immunoassay-based threat detection technologies by researchers from the Pacific National ... threat detection technology was found to have the best level of detection ...
Breaking Biology Technology: